Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors

REINHARD E. FRIEDRICH, LOUISA K. N. NÖRNBERG and CHRISTIAN HAGEL
Anticancer Research May 2022, 42 (5) 2327-2340; DOI: https://doi.org/10.21873/anticanres.15712
REINHARD E. FRIEDRICH
1Department of Oral and Craniomaxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rfriedrich{at}uke.de
LOUISA K. N. NÖRNBERG
2Institute of Neuropathology, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany;
3Institute of Veterinary Pathology, Justus Liebig University Gießen, Gießen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRISTIAN HAGEL
2Institute of Neuropathology, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 42 no. 5 2327-2340
DOI 
https://doi.org/10.21873/anticanres.15712
PMID 
35489721

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 21, 2022
  • Revision received March 28, 2022
  • Accepted March 31, 2022
  • Published online April 30, 2022.

Copyright & Usage 
Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. REINHARD E. FRIEDRICH1⇑*,
  2. LOUISA K. N. NÖRNBERG2,3,* and
  3. CHRISTIAN HAGEL2
  1. 1Department of Oral and Craniomaxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany;
  2. 2Institute of Neuropathology, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany;
  3. 3Institute of Veterinary Pathology, Justus Liebig University Gießen, Gießen, Germany
  1. Correspondence to: Professor Reinhard E. Friedrich, MD, DMD, PhD, FEBOMFS, Department of Oral and Craniomaxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Martinist. 52, D-20246 Hamburg, Germany. Tel: +49 40741053259, e-mail: rfriedrich{at}uke.de
  1. ↵* These Authors contributed equally to this study.

View Full Text

Statistics from Altmetric.com

Cited By...

  • 5 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 42, Issue 5
May 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors
REINHARD E. FRIEDRICH, LOUISA K. N. NÖRNBERG, CHRISTIAN HAGEL
Anticancer Research May 2022, 42 (5) 2327-2340; DOI: 10.21873/anticanres.15712

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors
REINHARD E. FRIEDRICH, LOUISA K. N. NÖRNBERG, CHRISTIAN HAGEL
Anticancer Research May 2022, 42 (5) 2327-2340; DOI: 10.21873/anticanres.15712
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • SNX-2112 inhibits the ERBB3high tumor population in Plexiform Neurofibromas
  • Google Scholar

More in this TOC Section

  • Growth Suppression and Selective Disruption of F-Actin by α-Santalol in Human Melanoma Cells
  • RPA1, RFC1, and POLE Expression in Clear Cell Renal Cell Carcinoma: Immune and Clinical Relevance
  • Inhibition of Cholesterol Transport from Lysosomes by Itraconazole Repolarizes Tumor-associated Macrophages to Anti-tumor M1 type
Show more Experimental Studies

Keywords

  • neurofibromatosis type 1
  • neurofibroma
  • plexiform neurofibroma
  • diffuse plexiform neurofibroma
  • neurofibroma classification
  • malignant peripheral nerve sheath tumor
  • ERBB2
  • ERBB3
  • NRG1
  • Ki-67
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire